Close Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Close Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$672K	Buy	3,535 +990	+39%	+$170K	0.02%	89
2026 Q1	$430K	Hold	2,545	–	–	0.01%	109
2025 Q4	$430K	Buy	2,545 +2,200	+638%	+$357K	0.01%	111
2025 Q3	$50K	Buy	345 +70	+25%	+$9.55K	﹤0.01%	171
2025 Q2	$35K	Hold	275	–	–	﹤0.01%	179
2025 Q1	$35K	Buy	275 +45	+20%	+$6.1K	﹤0.01%	168
2024 Q4	$30K	Hold	230	–	–	﹤0.01%	173
2024 Q3	$33K	Hold	230	–	–	﹤0.01%	180
2024 Q2	$32K	Hold	230	–	–	﹤0.01%	179
2024 Q1	$32K	Hold	230	–	–	﹤0.01%	176
2023 Q4	$31K	Sell	230 -78	-25%	-$9.52K	﹤0.01%	168
2023 Q3	$38K	Hold	308	–	–	﹤0.01%	152
2023 Q2	$39K	Hold	308	–	–	﹤0.01%	168
2023 Q1	$40K	Buy	308 +78	+34%	+$10.2K	﹤0.01%	151
2022 Q4	$30K	Hold	230	–	–	﹤0.01%	143
2022 Q3	$27K	Hold	230	–	–	﹤0.01%	134
2022 Q2	$27K	Buy	+230	New	+$27.3K	﹤0.01%	135
2018 Q1	–	Sell	-75	Closed	-$8K	–	226
2017 Q4	$8K	Hold	75	–	–	﹤0.01%	193
2017 Q3	$8K	Buy	+75	New	+$8.02K	﹤0.01%	183

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Close Asset Management's IBB Position: Q2 2026 in Review

Close Asset Management increased its iShares Biotechnology ETF (IBB) stake by 39% in Q2 2026, buying an estimated $170K and bringing the position to 3,535 shares worth $672K. The position accounts for 0.02% of the portfolio, ranked #89.

Close Asset Management first reported a position in IBB in Q3 2017 and has held it in 19 quarters since. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Close Asset Management held 3,535 shares of iShares Biotechnology ETF worth $672K as of Q2 2026.
Close Asset Management bought 990 iShares Biotechnology ETF shares in Q2 2026, an estimated $170K.
iShares Biotechnology ETF made up 0.02% of Close Asset Management's portfolio in Q2 2026, its #89 holding.
Close Asset Management first reported a position in iShares Biotechnology ETF in Q3 2017 and has held it in 19 quarters since.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Close Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.